linagliptin glp 1 Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Linagliptin: from bench to bedside
Description
Vibration-controlled transient elastography scores to predict liver-related events in steatotic liver disease
Typically, after two to four weeks of consistent use, most people experience a more pronounced and sustained reduction in hunger
Ahuja A et al
PLoS Med (2004) 1(1):e27.10.1371/journal.pmed.0010027 5 HotamisligilGS
These effects result in significant drowsiness during the day
Researchers also identified a dose response, meaning that the longer the patients took a GLP-1, the more likely they were to develop the condition
